Biogen Updates
May 15, 2026
On February 10, I wrote about Biogen’s Diranersen (BIIB080), an investigational drug designed to reduce the production of tau protein. Diranersen was developed by Ionis Pharmaceuticals. In late 2019,…
On February 10, I wrote about Biogen’s Diranersen (BIIB080), an investigational drug designed to reduce the production of tau protein. Diranersen was developed by Ionis Pharmaceuticals. In late 2019,…